KODKodiak Sciences Inc.

HealthcareUSD
$39.27

The financials

Kodiak Sciences Inc. by the numbers

Kodiak Sciences Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$67M−$56Mn/a
Net income−$66M−$54Mn/a
Diluted EPS−$1.05−$1.03n/a

Biotechnology

Ranks #125 of 145 by Smart Score

Compare peers
OCUL-0.91%
Ocular Therapeutix, Inc.
AGIO-0.22%
Agios Pharmaceuticals, Inc.
GENB+1.2%
Generate Biomedicines, Inc.
NKTR-4.3%
Nektar Therapeutics
ZLAB+0.82%
Zai Lab Limited
VCEL+2.9%
Vericel Corporation